These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 21609709

  • 41. CD36 c.1264 T>G null mutation impairs acquisition of IgG antibodies to Plasmodium falciparum MSP1₁₉ antigen and is associated with higher malaria incidences in Tanzanian children.
    Kajeguka D, Mwanziva C, Daou M, Ndaro A, Matondo S, Mbugi E, Dolmans W, Chilongola J.
    Scand J Immunol; 2012 Mar; 75(3):355-60. PubMed ID: 22050542
    [Abstract] [Full Text] [Related]

  • 42. Avidity of anti-malarial antibodies inversely related to transmission intensity at three sites in Uganda.
    Ssewanyana I, Arinaitwe E, Nankabirwa JI, Yeka A, Sullivan R, Kamya MR, Rosenthal PJ, Dorsey G, Mayanja-Kizza H, Drakeley C, Greenhouse B, Tetteh KK.
    Malar J; 2017 Feb 10; 16(1):67. PubMed ID: 28183299
    [Abstract] [Full Text] [Related]

  • 43. Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.
    Noland GS, Hendel-Paterson B, Min XM, Moormann AM, Vulule JM, Narum DL, Lanar DE, Kazura JW, John CC.
    Infect Immun; 2008 Dec 10; 76(12):5721-8. PubMed ID: 18809666
    [Abstract] [Full Text] [Related]

  • 44. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.
    Ahmed Ismail H, Tijani MK, Langer C, Reiling L, White MT, Beeson JG, Wahlgren M, Nwuba R, Persson KE.
    Malar J; 2014 Nov 05; 13():425. PubMed ID: 25373511
    [Abstract] [Full Text] [Related]

  • 45. The use of crude Plasmodium falciparum antigens for comparison of antibody responses in patients with mild malaria vs. cerebral malaria.
    Mbengue B, Niang B, Diatta B, Tall A, Garraud O, Perraut R, Dieye A.
    Iran J Immunol; 2010 Sep 05; 7(3):150-61. PubMed ID: 20876986
    [Abstract] [Full Text] [Related]

  • 46. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.
    Okech BA, Corran PH, Todd J, Joynson-Hicks A, Uthaipibull C, Egwang TG, Holder AA, Riley EM.
    Infect Immun; 2004 Mar 05; 72(3):1557-67. PubMed ID: 14977962
    [Abstract] [Full Text] [Related]

  • 47. Short report: differential evolution of immunoglobulin G1/G3 antibody responses to Plasmodium falciparum MSP1(19) over time in malaria-immune adult Senegalese patients.
    Diallo TO, Spiegel A, Diouf A, Lochouarn L, Kaslow DC, Tall A, Perraut R, Garraud O.
    Am J Trop Med Hyg; 2002 Feb 05; 66(2):137-9. PubMed ID: 12135282
    [Abstract] [Full Text] [Related]

  • 48. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.
    Egan AF, Morris J, Barnish G, Allen S, Greenwood BM, Kaslow DC, Holder AA, Riley EM.
    J Infect Dis; 1996 Mar 05; 173(3):765-9. PubMed ID: 8627050
    [Abstract] [Full Text] [Related]

  • 49. Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam.
    Wang L, Richie TL, Stowers A, Nhan DH, Coppel RL.
    Infect Immun; 2001 Jul 05; 69(7):4390-7. PubMed ID: 11401978
    [Abstract] [Full Text] [Related]

  • 50. Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname.
    Labadie-Bracho MY, van Genderen FT, Adhin MR.
    Malar J; 2020 Oct 08; 19(1):360. PubMed ID: 33032606
    [Abstract] [Full Text] [Related]

  • 51. Analysis of antibody responses to selected Plasmodium falciparum merozoite surface antigens in mild and cerebral malaria and associations with clinical outcomes.
    Mbengue B, Fall MM, Varela ML, Loucoubar C, Joos C, Fall B, Niang MS, Niang B, Mbow M, Dieye A, Perraut R.
    Clin Exp Immunol; 2019 Apr 08; 196(1):86-96. PubMed ID: 30580455
    [Abstract] [Full Text] [Related]

  • 52. Association of naturally acquired IgG antibodies against Plasmodium falciparum serine repeat antigen-5 with reduced placental parasitemia and normal birth weight in pregnant Ugandan women: a pilot study.
    Owalla TJ, Palacpac NM, Shirai H, Horii T, Egwang TG.
    Parasitol Int; 2013 Jun 08; 62(3):237-9. PubMed ID: 23395684
    [Abstract] [Full Text] [Related]

  • 53. Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi.
    Pirahmadi S, Zakeri S, A Mehrizi A, D Djadid N, Raz AA, J Sani J, Abbasi R, Ghorbanzadeh Z.
    Malar J; 2019 Apr 24; 18(1):146. PubMed ID: 31014347
    [Abstract] [Full Text] [Related]

  • 54. Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
    Gupta PK, Mukherjee P, Dhawan S, Pandey AK, Mazumdar S, Gaur D, Jain SK, Chauhan VS.
    Clin Vaccine Immunol; 2014 Jun 24; 21(6):886-97. PubMed ID: 24789797
    [Abstract] [Full Text] [Related]

  • 55. Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region.
    Braga EM, Barros RM, Reis TA, Fontes CJ, Morais CG, Martins MS, Krettli AU.
    Am J Trop Med Hyg; 2002 May 24; 66(5):461-6. PubMed ID: 12201577
    [Abstract] [Full Text] [Related]

  • 56. Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4.
    Chang SP, Kayatani AK, Terrientes ZI, Herrera S, Leke RG, Taylor DW.
    Malar J; 2010 Jan 13; 9():14. PubMed ID: 20070906
    [Abstract] [Full Text] [Related]

  • 57. The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas.
    Jepsen MP, Jogdand PS, Singh SK, Esen M, Christiansen M, Issifou S, Hounkpatin AB, Ateba-Ngoa U, Kremsner PG, Dziegiel MH, Olesen-Larsen S, Jepsen S, Mordmüller B, Theisen M.
    J Infect Dis; 2013 Aug 01; 208(3):479-88. PubMed ID: 23624363
    [Abstract] [Full Text] [Related]

  • 58. Specificity of the IgG antibody response to Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale MSP119 subunit proteins in multiplexed serologic assays.
    Priest JW, Plucinski MM, Huber CS, Rogier E, Mao B, Gregory CJ, Candrinho B, Colborn J, Barnwell JW.
    Malar J; 2018 Nov 09; 17(1):417. PubMed ID: 30413163
    [Abstract] [Full Text] [Related]

  • 59. Naturally acquired antibody responses to the components of the Plasmodium falciparum merozoite surface protein 1 complex.
    Wang L, Crouch L, Richie TL, Nhan DH, Coppel RL.
    Parasite Immunol; 2003 Nov 09; 25(8-9):403-12. PubMed ID: 14651587
    [Abstract] [Full Text] [Related]

  • 60. Kinetics of humoral and memory B cell response induced by the Plasmodium falciparum 19-kilodalton merozoite surface protein 1 in mice.
    Kafuye-Mlwilo MY, Mukherjee P, Chauhan VS.
    Infect Immun; 2012 Feb 09; 80(2):633-42. PubMed ID: 22104109
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.